Effective May 20, 2022ORS 475A.235 | Statutes/Other Implemented: ORS 475A.235Oregon Health Authority
(1) A manufacturer must design and manufacture all psilocybin products to be consumed by a client orally or delivered via another enteral method
(2) A manufacturer is prohibited from designing or manufacturing psilocybin products that can be delivered to clients through any method other than orally or another enteral method. A manufacturer is prohibited from designing or manufacturing psilocybin products that include but not limited to, transdermal patches, inhalers, nasal sprays, suppositories and injections.